# A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions

> **NCT00727272** · PHASE1 · COMPLETED · sponsor: **Mutual Pharmaceutical Company, Inc.** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Quinine Sulfate Capsules 324 mg
- **DRUG:** Quinine Sulphate Tablets 300 mg
- **DRUG:** Quinine Sulfate Capsules 324 mg

## Key facts

- **NCT ID:** NCT00727272
- **Lead sponsor:** Mutual Pharmaceutical Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2004-03
- **Final completion:** 2004-03
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2010-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727272, "A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00727272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*